Phase 3 N=835 Virtual Continuity and Its Impact on Complex Hospitalized Patients' Care
Automated Communication Tools · Complex Medical Patients
Primary: Medication Errors at Hospital Discharge — 645; 359 Errors
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=157 Managing Type 1 and High Risk Type 2 Diabetes in the Hospital Setting: Glucose as a Vital Sign
Diabetes Mellitus, Type 1 · Diabetes Mellitus, Type 2
Primary: Type 2 Diabetes Blood Glucose Time in Range (70-180 mg/dL) — 25.31; 19.89; 26.04 percentage of time during CGM use — p=0.1460
N/A N=1,500 Hospital to Home Outcomes
Focus: Hospitalized Patients
Primary: Number of Participants With Any Occurrence of Unplanned Re-hospitalization and/or Any Emergency/Urgent Care Visits Within 30 Days of Hospital Discharge — 133; 105…
N/A N=16 Inpatient Diabetes Mellitus (DM) Management With Continuous Glucose Monitoring Devices, a Pilot Study.
Diabetes Mellitus
Primary: Percentage of Time Spent in Hyperglycemia > 180 mg/dL — 35.47; 35.25 percentage of time spent > 180mg/dL
N/A N=129 Reducing Length of Stay for Veterans Hospitalized With Pneumonia
Pneumonia
Primary: Length of Hospital Stay — 7.3; 5.8 Days
N/A N=142 Continuous Glucose Monitoring in Hospitalized Patients With Diabetes Mellitus
Diabetes Mellitus
Primary: Continuous Glucose Monitors (CGM) Accuracy - Mean Absolute Relative Difference (MARD) — 22.6; 14.6; 11.7; 10.4 MARD percentage
N/A N=194 Short Stay Unit vs Hospitalization in Acute Heart Failure
Acute Heart Failure
Primary: Days Alive and Out of Hospital — 26.9; 25.4 Days Alive and Out of Hospital
Phase 4 N=1,270 Smoking Cessation in Hospitalized Smokers
Smoking Cessation
Primary: Percentage of Participants With 30-day Abstinence — 18.0; 23.4; 22.1; 18.7 percentage of participants
N/A N=31 Effect of Inpatient Diabetes Management on Outpatient Glycemic Control
Diabetes Mellitus, Type 2
Primary: Hemoglobin A1c — -1.3; -0.4 HbA1c, %
Phase 4 N=279 Sitagliptin Therapy in Hospitalized Patients With Type 2 Diabetes
Type 2 Diabetes
Primary: Mean Blood Glucose Concentration After First Day of Treatment — 9.5; 9.4 mmol/L
Phase 4 N=126 Prandial Insulin Dosing in Hospitalized Patients
Diabetes · Admitting Hospital · Non-critically Ill
Primary: Mean Glucose — 158; 171 mg/dl
N/A N=20 Preventing the Loss of Muscle and Function in Hospitalized Older Adults
Muscular Atrophy
Primary: The Percent Change in Bilateral Thigh Lean Mass Density (Grams) as Measured by DEXA Scan Will be Compared Between Baseline and After 5-days of Bed Rest — -3.845; -0.249…
N/A N=1,044 Implementation of HIT-Enhanced Tobacco Treatment for Hospitalized Smokers
Tobacco Use Cessation · Smoking Cessation · Smoking
Primary: Number of Participants With Exhaled Carbon Monoxide Confirmed Abstinence — 53; 65 participants
N/A N=300 HIV HOspital TEsting: Bringing the Hidden to Light in the Hospital Setting
Hiv · HIV Infections · AIDS
Primary: Prevalence of HIV Infection — 6 Participants
Phase 2 N=31 Vitamin D in Ventilated ICU Patients
Respiratory Failure
Primary: Number of Participants With Plasma 25(OH)D Concentration >30ng/mL at Baseline — 2; 2; 1 participants
N/A N=83 Improving Oral Care to Reduce Hospital-Acquired Pneumonia (HAP) in the Acute Neurologically Impaired Adult
Pneumonia
Primary: Hospital Acquired Pneumonia Occurrences — 2; 13 participants
N/A N=22 Automated Insulin Delivery for INpatients With DysGlycemia (AIDING) Feasibility
Diabetes Mellitus
Primary: Percentage of Time Spent in HCL After CGM Sensor Meets Initial Validation Criteria — 91 percentage of time
N/A N=44 Hospital-based Patient Navigation and Smoking Cessation
Smoking Cessation
Primary: Number of Participants With Prescription for an FDA-approved Smoking Cessation Medication — 9; 11 Participants
N/A N=3,362 Actions Elicited by In-hospital Follow-up of Cardiac Devices
Cardiac Pacemaker, Artificial · Implantable Cardioverter-Defibrillator
Primary: Number of Patients of the Whole Population in Whom Something (Therapy, Device Programming ...) Has Been Changed During In-hospital Follow-up — 767 Participants
N/A N=366 Undiagnosed Hepatitis C Infection in an Urban Hospital
Hepatitis C
Primary: Point Prevalence of Hepatitis C Infection — 9 percentage of total subjects
Phase 2 N=100 Efficacy and Safety of a Hospital Walking Program for Older Adults
Acute Disease
Primary: Falls — 0; 2 participants — p=<.05
N/A N=1,492 The Etiology of Acute Febrile Illness Requiring Hospitalization
Acute Febrile Illness
Primary: The Etiologies (Bacteria, Viruses, Parasites, Fungi and Others) of Fever Illness Expressed in Percentages of Enrolled Subjects. — 621; 362; 15; 5 Participants
N/A N=385 Improving Patient Walking During Hospitalization
Early Mobility · Older Adults · Hospital Acquired Condition
Primary: Aim 1: Change in Gait Speed — 0.67; 0.73; 0.73; 0.77 m/s — p=0.674
N/A N=54 Reducing Behavioral and Psychological Symptoms of Dementia: Hospital Caregivers (Aim 2)
Alzheimer's Disease and Related Dementias
Primary: Change in Approaches to Dementia Questionnaire (ADQ) Total Score From Baseline to 3 Months — -1.8; -2.3 units on a scale
N/A N=966 Supplement to Hospital to Home Outcomes
Hospitalized Patients
Primary: Number of Participants With Any Occurrence of Unplanned Re-hospitalization and/or Any Emergency/Urgent Care Visits Within 30 Days of Hospital Discharge — 77; 63…
Early Phase 1 N=44 Inpatient Single Dose Interventions for Alcohol Use Disorder
Alcohol Use Disorder, Severe
Primary: Rate (%) of 30-day Hospital Re-admission — 3; 2; 7 Participants
N/A N=164 Smoking Cessation After Hospitalization for a Cardiopulmonary Illness
Smoking Cessation
Primary: Abstinence From Smoking — 15; 7; 13; 10 percentage of participants
N/A N=1,357 Comparative Effectiveness of Post-Discharge Strategies for Hospitalized Smokers
Cigarette Smoking · Tobacco Smoking · Tobacco Use Disorder
Primary: Tobacco Abstinence - 6 Month Follow-up — 105; 113 Participants — p=>0.05
Phase 4 N=130 Insulin Detemir Versus NPH Insulin In Hospitalized Patients With Diabetes
Type 2 Diabetes
Primary: Mean AM BG (mg/dl) — 144; 155 mg/dl
N/A N=4,832 An Evaluation of Post Discharge Utilization Among Patients With an Acute Exacerbation of COPD
Chronic Obstructive Pulmonary Disease
Primary: Healthcare Utilization — 1080; 920 Participants — p=0.041